Blood Testing Market, By Test Type (Complete Blood Test, Kidney Test-Renal Profile, Cholesterol Test-Lipid Profile Test, Blood Glucose Test, Antibodies Test-Rheumatoid factor, Urine Test, Infectious Disease Screening, Cancer Test, Heart Test), By Product ( Instruments, Reagents & Kits, Software), Disease (Anemia, Infection, Leukemia), By Method ( Manual Blood Testing, Automated Blood Testing), , By End Use (Hospitals, Pathology Labs, Blood Banks, Diagnostic Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032

A blood test is a laboratory analysis of what is found in your blood You may have blood tests to monitor how well you are managing a condition, such as diabetes or high cholesterol, for routine checkups or when you are sick. Certain blood tests can help the doctor determine how different organs in the body are working, examples of organs that may show abnormalities in blood tests include the thyroid, liver or kidneys. A blood test usually consists of three main tests such as a complete blood count, a metabolic panel and a lipid panel. Regular blood tests are an important way to keep track of your overall health, getting tested regularly can help you visualize changes in your body as you age and empower you to make informed decisions about your health, blood tests provide an important picture of your overall health and well-being . A complete blood count is a blood test used to assess overall health and detect a variety of disorders, including anemia, infection and leukemia, while blood tests can show normal or abnormal levels for many conditions, they may not always indicate health-care professionals because of specific symptoms, Tkachuk said. Most doctors recommend that you get blood work done once a year, during your annual physical, the three essential lab tests are routine blood work, A1C test and lipid panel, these tests can provide comprehensive insight into your current health status. Blood tests are very common, ordered by healthcare providers to help diagnose diseases such as cancer, diabetes, coronary heart disease, and HIV/AIDS, to find out how well organs like your kidneys, liver, heart, or thyroid are working, find out. A blood test is a laboratory testing procedure that determines a patient's health status based on a blood sample that determines how well the organs are working. These tests are inexpensive and are commonly performed in clinics and hospitals as important screening tests to detect any mild to severe disease. A blood test usually involves taking a blood sample from a vein in your arm, the hand being a convenient part of the body to use because it can be easily dislocated, and the usual place to take the sample. Inside the elbow or wrist, where the veins are relatively close to the surface. The multinational health care organization supports the discovery of innovative techniques and raises awareness about the eradication and diagnosis of common as well as chronic disorders, providing strong external funding to clinical studies conducted for the development of new innovative diagnostics with the aim of promoting the market. In this market, the increasing prevalence of infectious disorders such as diabetes, Covid-19 and cardiovascular diseases is likely to drive the growth of the blood testing market.

The primary growth drivers of the blood-testing sector are the huge increase in chronic diseases and the increasing awareness of the global population about their own health, the growing number of individuals suffering from pathogens will give a strong boost to the sector. Rising demand for home healthcare and introduction of advanced technology-enabled products and increasing medical spending by government and regulatory bodies are expected to drive the market over the forecast period and also Increasing burden of chronic and infectious diseases, new technological advancements in blood testing devices, increasing number of point-of-care testing centers and increasing demand for CBC tests during the Covid-19 pandemic are likely to drive the growth of the blood testing market. Strong external funding of clinical studies conducted to boost the market, introduction of constructive regulatory parameters aimed at promoting the use of POC testing is a high-impact driver of the market and on the other hand, stringent regulatory approval process is restricting the market growth. However, lack of awareness about recent advancements, regulatory approval process and high cost of automated blood testing will hinder the market growth in the coming years.

Technological advancement

Micro sampling technology is used in the process of blood testing, this technology offers solutions for high quality, volumetric and accurate collection, transport and storage of blood. The outbreak of the Covid-19 pandemic is expected to provide lucrative opportunities for major companies to expand their markets and offer innovative glucose tracking product offerings. Technological advancements are driving test adoption, smart glucose tracking devices include iHealth smart, iHealth Align, Dario Health Smart Meter and Glooko. Blood tests include some important blood testing technologies such as rapid diagnostic test kits, micro sampling technology, glucose meters, blood chemistry analyzers, complete blood count tests. Manufactures involved in Blood testing Market are developing advanced versions of their products due to new age technological advancements. Key players of Blood testing are investing more in power systems and creating more modern, timesaving, cost-effective technology that has a positive impact on the Blood testing market. In June 2022, Apollo Cancer Centers in partnership with Datar Cancer Genetics launched a blood test that can detect breast cancer at an early stage in asymptomatic individuals.

On the basis of test type, the Blood Testing Market is segmented into Complete Blood Test, Kidney Test-Renal Profile, Cholesterol Test-Lipid Profile Test, Blood Glucose Test, Antibodies Test-Rheumatoid factor, Urine Test, Infectious Disease Screening, Cancer Test, and Heart Test. On the basis of product, the target market is classified into Instruments, Reagents & Kits, and Software. On the basis of disease, the Blood Testing Market is segmented into Anemia, Infection, and Leukemia. On the basis of method, the target market is classified into Manual Blood Testing, Automated Blood Testing. On the basis of end user, the Blood Testing Market is segmented into Hospitals, Pathology Labs, Blood Banks, and Diagnostic Centers.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

On region the Blood Testing Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America region accounts for the largest medical testing market share in the global blood testing market due to increasing incidence of diseases such as kidney disorders, blood stream infections, other infections, high demand for rapid diagnostic tests and aging population. The Asia Pacific region is expected to grow rapidly during the forecast period due to increasing awareness about the importance of diagnostics in personalized medicine and government initiatives promoting the use of personalized medicine.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Blood Testing Market report based on test type, product, disease, method, end user and region:

Blood Testing Market, By Test Type:

• Complete Blood Test
• Kidney Test-Renal Profile
• Cholesterol Test-Lipid Profile Test
• Blood Glucose Test
• Antibodies Test-Rheumatoid factor
• Urine Test
• Infectious Disease Screening
• Cancer Test
• Heart Test

Blood Testing Market, By Product:

• Instruments
• Reagents & Kits
• Software

Blood Testing Market, By Disease:

• Anemia
• Infection
• Leukemia

Blood Testing Market, By Method:

• Manual Blood Testing
• Automated Blood Testing

Blood Testing Market, By End User:

• Hospitals
• Pathology Labs
• Blood Banks
• Diagnostic Centers

Blood Testing Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating the Blood Testing Market includes, BioRad Laboratories, Danaher Corporation, Abbott Laboratories, BioMerieux SA, Thermo Fisher Scientific, Siemens Healthineers, Sinocare Inc., Biomerica, Hoffmann-La Roche Ltd, and Trinity Biotech.

• BioRad Laboratories*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Danaher Corporation
• Abbott Laboratories
• BioMerieux SA
• Thermo Fisher Scientific
• Siemens Healthineers
• Sinocare Inc.
• Biomerica
• Hoffmann-La Roche Ltd
• Trinity Biotech
• Becton

 “*” marked represents similar segmentation in other categories in the respective section

Recent Developments:

• In August 2022, Thermo Fisher Scientific launched a new automated dry blood spot sampling and analysis system, the Thermo Scientific Transcend DSX-1 integrated sample prep and ultra-high performance liquid chromatography system offering high throughput, sensitive and tailored analysis.
• In April 2020, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced that the company is launching a blood-based immunoassay kit to detect antibodies to the virus associated with the coronavirus SARS-CoV-2, including COVID-19.
• In August 2022, Biomerica, Inc. announced plans to launch its InFoods IBS trial before the end of the calendar year. The test will be performed in a CLIA-certified, high-complexity laboratory and will be offered as a laboratory-developed test. In preparation for the launch of InFoods IBS, the company announced the appointment of Robert Carlson as the company's Chief Commercial Officer.